You have no items in your shopping cart.
Search results for: 'apoptosis'
Biotinylated Human PCSK9 (C-Avi) [orb2993453]Predicted: 14&59 KDa. Observed: 19&65 KDa, reducing conditions
100 μg, 20 μg- Recombinant Human PCSK9 (C-6His) [orb2993454]
Predicted: 13.77&58.2 KDa. Observed: 19&60 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human PDCD5 (N-6His) [orb2994625]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 16.4 KDa. Observed: 20 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human PDCD10 [orb2994641]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 24.9 KDa. Observed: 28 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human BIRC5 [orb2994652]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 16.4 KDa. Observed: 16-18 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human FAS (C-6His) [orb2994747]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 17.7 KDa. Observed: 22-42 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human TRAIL R3 (C-6His) [orb2995031]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 21.78 KDa. Observed: 38-58 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Mouse CD5L (C-6His) [orb2994911]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 37.43 KDa. Observed: 52 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human TRAIL R2 (C-6His) [orb2995140]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 15.3 KDa. Observed: 16-22 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Recombinant Human AIF (N-6His) [orb2995176]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 56.2 KDa. Observed: 68 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg